.While the biotech assets performance in Europe has decreased relatively complying with a COVID-19 f...
.After rearing $213 thousand in 2023-- one of the year's most extensive private biotech rounds-- Tom...
.Invite to this week's Chutes & Ladders, our summary of considerable leadership hirings, shooting...
.Financial backing financing in to biopharma rose to $9.2 billion around 215 deals in the 2nd fourth...
.Bicara Therapeutics and Zenas Biopharma have actually delivered new impetus to the IPO market with ...
.Genentech is going to shut its cancer immunology research study division, and device head as well a...
.Kezar Lifestyle Sciences is falling its own unpromising phase 1 solid lump drug as the biotech goes...
.Regardless of izokibep maintaining its own newfound winning streak in the center, Acelyrin is no mo...
.Rivus Pharmaceuticals has actually plumped up the prospects of its own fat-busting, muscle-sparing ...
.Ovid Therapy currently uncovered last month that it was trimming back its headcount as the company ...